Clinical use of artificial intelligence products for radiology in the Netherlands between 2020 and 2022.

Journal: European radiology
Published Date:

Abstract

OBJECTIVES: To map the clinical use of CE-marked artificial intelligence (AI)-based software in radiology departments in the Netherlands (n = 69) between 2020 and 2022.

Authors

  • Kicky G van Leeuwen
    Department of Medical Imaging, Radboud university medical center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. kicky.vanleeuwen@radboudumc.nl.
  • Maarten de Rooij
    Department of Medical Imaging, Radboud university medical center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Steven Schalekamp
    From the Diagnostic Image Analysis Group, Radboud University Medical Center, Geert Groteplein 10, Nijmegen 6500 HB, the Netherlands (K.M., E.T.S., S.S., C.M.S., B.v.G.); Department of Radiology, Bernhoven Hospital, Uden, the Netherlands (H.S.); Department of Radiology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands (A.J.G.K., M.B.J.M.K., T.S., M.R.); Department of Radiology, Meander Medisch Centrum, Amersfoort, the Netherlands (C.M.S.); and Thirona, Nijmegen, the Netherlands (R.H.H.M.P., A.M., J.M.).
  • Bram van Ginneken
    Diagnostic Image Analysis Group, Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Fraunhofer Mevis, Bremen, Germany.
  • Matthieu J C M Rutten
    Department of Medical Imaging, Radboud university medical center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.